allowing drug companies to offer discounted prices directly to consumers, aiming to stop the controversial rebate practice. But those rules would apply only to Medicare drug plans and Medicaid managed-care plans.
During last week’s testimony by drug executives before the Senate Finance Committee, Chairman Chuck Grassley asked whether their companies would lower prices if the Trump rule applying to public-sector plans is ultimately implemented. they would be willing to lower prices if rebates were banned in the private sector, too.
During the hearing, Bristol-Myers Squibb chief executive Giovanni Caforio said he shared the same position. After a follow-up question, Bristol-Myers Squibb said it remains “committed to working with Congress and the Administration on reforming the rebate system with a focus on what is best for patients.”After the hearing, Sen.
"[T]he legislation appears to do absolutely nothing to address the root cause of the problem: high list prices that only the drug manufacturers have the power to set," J.C. Scott, president of the Pharmaceutical Care Management Association, told The Health 202 in a statement."Despite drug manufacturers’ rhetoric, their pricing strategies are unrelated to the rebates they negotiate with PBMs.
“This bill doesn’t outlaw PBMs. It doesn’t even outlaw rebates. What it’s going to do is shed light on the process so they’re not going to be able to get by with the argument that there’s room for a whole other layer of a middleman,” Braun said. “You don’t need it."AHH, OOF and OUCH
Key figure in this tweet: '1' Only ONE single Republican senator is actually pushing for what the GOP promised. One. Progress? 🇷🇺🐘💩
The pharmacy industry has proven , again and again, that it is a predatory monopolistic industry. Serious regulation is necessary.
Isn’t he the guy that defeated Joe Donnelly (D) last November? 😏
The GOP thinks they can just ask corporations nicely to do the right thing even though there are very few cases that ever happens
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: CNBC - 🏆 12. / 72 Read more »